Filing Flows › Comparisons › PTHS vs IVVD
Pelthos Therapeutics vs Invivyd: PTHS and IVVD compared
Pelthos Therapeutics is the larger company: $15.6M of revenue in its latest quarter (Q2 2026) against $14.3M for Invivyd (Q2 2026). Pelthos Therapeutics is more profitable, with an operating margin of -111.0% against -320.8%.
Where the money goes: PTHS and IVVD
Pelthos Therapeutics (PTHS) · Q2 2026
Pelthos Therapeutics, Q2 2026: revenue $15.6M, operating margin -111.0%, net loss $23.4M, operating cash flow −$7.7M. The chart follows the revenue to costs, profit and cash.
Invivyd (IVVD) · Q2 2026
Invivyd, Q2 2026: revenue $14.3M (+21% year over year), operating margin -320.8%, net loss $44.4M, operating cash flow −$43.0M. The chart follows the revenue to costs, profit and cash.
| Pelthos Therapeutics (PTHS) | Invivyd (IVVD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $15.6M | $14.3M |
| Revenue growth, Y/Y | — | +21% |
| Operating margin | -111.0% | -320.8% |
| Net earnings | −$23.4M | −$44.4M |
| Net margin | -150.1% | -310.8% |
| Operating cash flow | −$7.7M | −$43.0M |
Where the revenue comes from
Pelthos Therapeutics
- Net product revenues: $15.4M (99%)
- License and collaboration revenues: $183K (1%)
Questions
Which is bigger, Pelthos Therapeutics or Invivyd?
Pelthos Therapeutics is the larger company: $15.6M of revenue in its latest quarter (Q2 2026) against $14.3M for Invivyd (Q2 2026).
Is Pelthos Therapeutics or Invivyd growing faster?
Pelthos Therapeutics is more profitable, with an operating margin of -111.0% against -320.8%.
More: Pelthos Therapeutics earnings · how Pelthos Therapeutics makes money · Invivyd earnings · how Invivyd makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.